Article Sidebar
Views PDF: 44
The value of MSCT in diagnosing of mesenteric tumors
Main Article Content
Abstract
Objectives: Evaluating the value of MSCT in diagnosing of mesenteric tumors.
Subjects and Methods: including 55 patients from October 2010 to June 2014 with MSCT and with the sugery result and
pathology of mesenteric tumor, Gist (Gastrointestinal stroma tumor), retroperitoneal tumor.
Result: Determining diagnosic: Se: 86.5%, Sp: 92.9%, PPV: 64%. Local fat invasion: Se: 86.6%, Sp: 86.3%, ACC: 86.4%.
Evaluating vasculary invasion: Se: 66.6%, Sp: 92.8%, ACC: 86.4%.Evaluating gastrotestinal invasion: Se: 69.2%, Sp: 91.6%, ACC:
83.7%. Evaluating exact location of tumor: 35.1%. Evaluating peritoneal invasion: Se:71.4%, Sp: 90%, ACC: 86.4%.
Conclusion: MSCT has hight Se and Sp in determining diagnosis, evaluating the invasion level of mesenteric tumor. MSCT
has average PPV and low value in evaluating exact location of mesenteric tumor.
Article Details
Keywords
MSCT, Gist, mesenteric tumor, retroperitoneal tumor
References
2. Đỗ Xuân Hợp (1968), Giải phẫu người, NXB Y học và thể dục thể thao.
3. Xie Hong, MD, PhD,Haesun Choi, MD,et al (2006).Gastrointestinal Stromal Tumor: Role of CT in Diagnosis and in Response Evaluation and Surveillance after Treatment. RadioGraphics 2006; 26:481–495.
4. Sheila Sheth, MD. Karen M.Horton, MD . Melissa R.Garland, MS. Elliot K.Fishman, MD (2003), Mesenteric Neoplasms: CT Apperances of primary
and secondary tumors and differential Diagnosic, RadioGraphics 2003; 23:457–473.
5. Angela Levy MD (2009), peritoneum and mesenterypart II-pathology,http://www.radiologyassistant.nl/en/p4a6c7bba1ef26/peritoneum-and-mesentery-part-iipathology. html, truy cập ngày 9/11/2014.